Pneumopathies interstitielles diffuses au cours de la polyarthrite rhumatoïde

Turesson, 2003, Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years, Ann Rheum Dis, 62, 722, 10.1136/ard.62.8.722 Raghu, 2011, An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am J Respir Crit Care Med, 183, 788, 10.1164/rccm.2009-040GL Olson, 2011, Rheumatoid arthritis-interstitial lung disease-associated mortality, Am J Respir Crit Care Med, 183, 372, 10.1164/rccm.201004-0622OC Gabbay, 1997, Interstitial lung disease in recent onset rheumatoid arthritis, Am J Respir Crit Care Med, 156, 528, 10.1164/ajrccm.156.2.9609016 Bongartz, 2010, Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study, Arthritis and rheumatism, 62, 1583, 10.1002/art.27405 Brown, 2007, Rheumatoid lung disease, Proc Am Thorac Soc, 4, 443, 10.1513/pats.200703-045MS Habib, 2011, Pulmonary involvement in early rheumatoid arthritis patients, Clin Rheum, 30, 217, 10.1007/s10067-010-1492-5 Chen, 2013, Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease, Clin Dev Immunol, 2013, 406927, 10.1155/2013/406927 Cavagna, 2013, The multifaceted aspects of interstitial lung disease in rheumatoid arthritis, Biomed Res Int, 2013, 759760, 10.1155/2013/759760 Myasoedova, 2011, Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995–2007 versus 1985–1994: a population-based study, J Rheumatol, 38, 983, 10.3899/jrheum.101133 Bartels, 2010, Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years, Rheumatology, 49, 1670, 10.1093/rheumatology/keq135 Saag, 1996, Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities, Arthritis Rheum, 39, 1711, 10.1002/art.1780391014 de Lauretis, 2011, Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?, Chron Respir Dis, 8, 53, 10.1177/1479972310393758 Perez-Dorame, 2015, Rheumatoid arthritis-associated interstitial lung disease: lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity, Reumatol Clin, 11, 12, 10.1016/j.reuma.2014.02.007 Restrepo, 2015, Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis, Clin Rheumatol, 34, 1529, 10.1007/s10067-015-3025-8 Rocha-Munoz, 2015, Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis, J Immunol Res, 2015, 151626, 10.1155/2015/151626 Aubart, 2011, High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis, J Rheumatol, 38, 979, 10.3899/jrheum.101261 Ytterberg, 2015, Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation, Ann Rheum Dis, 74, 1772, 10.1136/annrheumdis-2013-204912 Kelly, 2014, Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics — A large multicentre UK study, Rheumatology, 53, 1676, 10.1093/rheumatology/keu165 Zhu, 2014, A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity, J Rheumatol, 41, 1282, 10.3899/jrheum.131341 Giles, 2014, Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease, Ann Rheum Dis, 73, 1487, 10.1136/annrheumdis-2012-203160 Park, 2016, Visual assessment of chest computed tomography findings in anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis: is it associated with airway abnormalities?, Lung, 194, 97, 10.1007/s00408-015-9828-1 Fischer, 2012, Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease, Respir Med, 106, 1040, 10.1016/j.rmed.2012.03.006 Alunno, 2018, Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis, Rheumatology, 10.1093/rheumatology/kex520 Klareskog, 2008, Immunity to citrullinated proteins in rheumatoid arthritis, Ann Rev Immunol, 26, 651, 10.1146/annurev.immunol.26.021607.090244 Joshua, 2017, Role of the lung in individuals at risk of rheumatoid arthritis, Best Pract Res Clin Rheumatol, 31, 31, 10.1016/j.berh.2017.08.002 Padyukov, 2004, A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis, Arthritis Rheum, 50, 3085, 10.1002/art.20553 Lundstrom, 2009, Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important, Arthritis Rheum, 60, 1597, 10.1002/art.24572 Stolt, 2005, Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study, Ann Rheum Dis, 64, 582, 10.1136/ard.2004.022053 Caplan, 1963, Contribution to discussion on rheumatoid pneumoconiosis, Grundfragen aus der Silikoseforschung, 6, 345 Too, 2016, Occupational exposure to textile dust increases the risk of rheumatoid arthritis: results from a Malaysian population-based case-control study, Ann Rheum Dis, 75, 997, 10.1136/annrheumdis-2015-208278 Assayag, 2014, Predictors of mortality in rheumatoid arthritis-related interstitial lung disease, Respirology, 19, 493, 10.1111/resp.12234 Johnson, 2016, Smoking and subclinical ILD in RA versus the multi-ethnic study of atherosclerosis, PloS One, 11, e0153024, 10.1371/journal.pone.0153024 Sebastiani, 2016, Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease, Clin Exp Rheumatol, 34, 564 Hirabayashi, 2006, Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis, Intern Med, 45, 689, 10.2169/internalmedicine.45.1455 Sato, 2009, Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis, Rheumatology, 48, 1265, 10.1093/rheumatology/kep227 Perez-Alvarez, 2011, Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases, Semin Arthritis Rheum, 41, 256, 10.1016/j.semarthrit.2010.11.002 Casanova, 2015, Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease, World J Gastroenterol, 21, 2260, 10.3748/wjg.v21.i7.2260 Leger, 2011, [Interstitial pneumonia after infliximab therapy for psoriasis], Ann Dermatol Venereol, 138, 499, 10.1016/j.annder.2011.01.043 Liote, 2010, Rituximab-induced lung disease: a systematic literature review, Eur Respir J, 35, 681, 10.1183/09031936.00080209 Ergin, 2012, Rituximab-induced bronchiolitis obliterans organizing pneumonia, Case Rep Med, 2012, 680431, 10.1155/2012/680431 Furukawa, 2012, Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope, PloS One, 7, e33133, 10.1371/journal.pone.0033133 Oka, 2016, Association of human leukocyte antigen alleles with chronic lung diseases in rheumatoid arthritis, Rheumatology, 55, 1301, 10.1093/rheumatology/kew025 Juge, 2017, Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis, Eur Respir J, 10.1183/13993003.02314-2016 Seibold, 2011, A common MUC5B promoter polymorphism and pulmonary fibrosis, N Engl J Med, 364, 1503, 10.1056/NEJMoa1013660 Nielen, 2004, Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors, Arthritis Rheum, 50, 380, 10.1002/art.20018 Verpoort, 2006, Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response, Arthritis Rheum, 54, 3799, 10.1002/art.22279 Klareskog, 2006, A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination, Arthritis Rheum, 54, 38, 10.1002/art.21575 Makrygiannakis, 2008, Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells, Ann Rheum Dis, 67, 1488, 10.1136/ard.2007.075192 Rangel-Moreno, 2006, Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis, J Clin Investig, 116, 3183, 10.1172/JCI28756 Brusselle, 2011, New insights into the immunology of chronic obstructive pulmonary disease, Lancet, 378, 1015, 10.1016/S0140-6736(11)60988-4 Foo, 2010, Regulation of inducible BALT formation and contribution to immunity and pathology, Mucosal Immunol, 3, 537, 10.1038/mi.2010.52 Bernstein, 2016, Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis, Thorax, 71, 1082, 10.1136/thoraxjnl-2016-208932 Kim, 2006, Interstitial lung disease in rheumatoid arthritis: recent advances, Curr Opin Pulm Med, 12, 346, 10.1097/01.mcp.0000239552.55326.ee Hallowell, 2014, Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced, Drugs, 74, 443, 10.1007/s40265-014-0190-z Kim, 2010, Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease, Eur Respir J, 35, 1322, 10.1183/09031936.00092309 Marigliano, 2013, Lung involvement in connective tissue diseases: a comprehensive review and a focus on rheumatoid arthritis, Autoimmun Rev, 12, 1076, 10.1016/j.autrev.2013.05.001 Solomon, 2016, Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease, Eur Respir J, 47, 588, 10.1183/13993003.00357-2015 Yunt, 2017, High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival, Respir Med, 126, 100, 10.1016/j.rmed.2017.03.027 Kim, 2009, Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern, Chest, 136, 1397, 10.1378/chest.09-0444 Nakamura, 2012, Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases, Respir Med, 106, 1164, 10.1016/j.rmed.2012.04.004 Solomon, 2013, Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), Respir Med, 107, 1247, 10.1016/j.rmed.2013.05.002 Roschmann, 1987, Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy, Semin Arthritis Rheum, 16, 174, 10.1016/0049-0172(87)90020-5 Ascherman, 2010, Interstitial lung disease in rheumatoid arthritis, Curr Rheumatol Rep, 12, 363, 10.1007/s11926-010-0116-z Ogawa, 2000, Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis, Rheumatology, 39, 1422, 10.1093/rheumatology/39.12.1422 Chang, 2002, Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report, J Korean Med Sci, 17, 270, 10.3346/jkms.2002.17.2.270 Saketkoo, 2009, Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects, Am J Med Sci, 337, 329, 10.1097/MAJ.0b013e31818d094b Fischer, 2013, Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease, J Rheumatol, 40, 640, 10.3899/jrheum.121043 O’Dwyer, 2013, Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD), Eur J Internal Med, 24, 597, 10.1016/j.ejim.2013.07.004 Noble, 2011, Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials, Lancet, 377, 1760, 10.1016/S0140-6736(11)60405-4 Richeldi, 2014, Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, N Engl J Med, 370, 2071, 10.1056/NEJMoa1402584 Kim, 2017, Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis, Rheumatol Int, 37, 1735, 10.1007/s00296-017-3781-7 Fernandez-Diaz, 2018, Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients, Semin Arthritis Rheum, 10.1016/j.semarthrit.2017.12.012 Doyle, 2014, A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease, Chest, 145, 454, 10.1378/chest.13-2408